11 – 20 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pregnancy outcomes in female survivors of neuroblastoma : a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
(
- Contribution to journal › Article
- 2022
-
Mark
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma : A potential treatment target in rare cases?
(
- Contribution to journal › Article
-
Mark
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
(
- Contribution to journal › Article
-
Mark
Amplification of CDK4 and MDM2 : a detailed study of a high-risk neuroblastoma subgroup
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
(
- Contribution to journal › Article
-
Mark
Is there a choice when a sibling is ill? Experiences of children and adolescents who donated stem cells to a sibling
(
- Contribution to journal › Article
- 2021
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
(
- Contribution to journal › Letter
-
Mark
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
(
- Contribution to journal › Article
-
Mark
The pediatric precision oncology INFORM registry : clinical outcome and benefit for patients with very high-evidence targets
(
- Contribution to journal › Article
-
Mark
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
(
- Contribution to journal › Article